Boston, Mass. October 18, 2017 – The Congress of Neurological Surgeons (CNS) is proud to announce Dr. Richard G. Ellenbogen of the University of Washington as the recipient of the 2017 CNS Distinguished Service Award. This award was presented during the 64th Annual Meeting of the CNS held at the Boston Convention and Exhibition Center.
The Distinguished Service Award is the most prestigious award that the Congress of Neurological Surgeons can bestow on an individual. Dr. Ellenbogen was specifically selected because of his critical and fundamental contributions to the specialty of neurological surgery and the broader medical community.
“The award recognizes that his work has indelibly shaped the field through the improved care of patients, the enriched training of neurosurgeons, outstanding leadership and scientific advancement,” said Russell Lonser, MD, CNS past president, and a member of the award’s selection committee. “In short, Dr. Ellenbogen represents the best of neurosurgery both in his contributions, as well as character.”
Dr. Ellenbogen’s selection was the unanimous decision of the award selection committee and underscores the profound impact that he has had on neurosurgery and the respect that he commands across our field. Dr. Ellenbogen is the co-chairmen of the National Football League’s (NFL) Head, Neck and Spine Committee, where he advises the League on best practices and research trends. His efforts in this area, including work on the NFL’s $100 million investment in concussion/chronic traumatic encephalopathy (CTE) research, has earned him special recognition from across the neurosurgical and athletic fields.
Outside of his work with the University of Washington and the NFL, Dr. Ellenbogen conducts significant research work with the National Institutes of Health (NIH). His NIH research projects have covered two disparate topics. He has been funded to study the CSF physiology, MRI anatomy and clinical presentation of patients with Chiari malformations, and is on an NIH contract to study the application of nanotechnology to targeted molecular therapies and molecular imaging of pediatric brain tumors.
Dr. Ellenbogen is a past president of the CNS (2006). He is also a recipient of the Bronze Star for his service during Operation Desert Storm/Desert Shield serving as Commander of the 252nd Medical (Neurosurgical)/XVIII Airborne Corp. Prior to his arrival at the University of Washington in 1997, Dr. Ellenbogen was selected as the first chairman of the combined Neurosurgical Residency Programs of Bethesda Naval Hospital and Walter Reed Army Medical Center.